Daniel Carlat, MD. Medical Director of Inpatient Psychiatry/Chairman of Psychiatry at Melrose Wakefield Healthcare. Publisher, Carlat Publishing.
Dr. Carlat has no financial relationships with companies related to this material.
.webp?height=400&t=1734559907&width=600 "shutterstock_2327421053(1).jpg")
Daniel Carlat, MD. Vice Chair, Community and Public Sector Psychiatry, Tufts University School of Medicine. Publisher, Carlat Publishing.
Dr. Carlat has no financial relationships with companies related to this material.
Daniel Carlat, MD. Medical Director of Inpatient Psychiatry/Chairman of Psychiatry at Melrose Wakefield Healthcare. Publisher, Carlat Publishing. Dr. Carlat has no financial relationships with companies related to this material.
Jennifer Leavitt, MS. PhD(c). Ms. Leavitt has no financial relationships with companies related to this material.
Daniel Carlat, MD. Medical Director of Inpatient Psychiatry/Chairman of Psychiatry at Melrose Wakefield Healthcare. Publisher, Carlat Publishing.
Dr. Carlat has no financial relationships with companies related to this material.
Alec L. Miller, PsyD. Co-Founder and Co-Director, Cognitive & Behavioral Consultants of Westchester, LLP, White Plains, NY; President, Access Psychology Foundation; Clinical Professor of Psychiatry and Behavioral Sciences Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, NY. He is also co-author of three textbooks published by Guilford Press applying dialectical behavioral therapy to adolescents in clinical and school settings.
Dr. Miller discloses that he receives royalties from Guilford Press and PsychWire. This educational activity has been reviewed and it has been determined that there is no commercial bias as a result of this financial relationship.
Mark L. Ruffalo, MSW, DPsa. Editor in Chief, The Carlat Psychotherapy Report, psychotherapist in private practice in Tampa, Florida, and Assistant Professor of Psychiatry at the University of Central Florida College of Medicine and Adjunct Instructor of Psychiatry at Tufts University School of Medicine. He has broad clinical experience in the psychoanalytic treatment of mood, personality, and psychosomatic disorders, and has particular interest in the psychotherapy of schizophrenia and borderline personality disorder.
Dr. Ruffalo has no financial relationships with companies related to this material.
Jeremy Mills, DNP, PHNP-BC, and Anthony Charuvastra, MD. The authors have no financial relationships with companies related to this material.
Thanos Karatzias, PsyDip, MSc, PhD, CPsychol. Edinburgh Napier University, School of Health & Social Care, Edinburgh, Scotland.
Dr. Karatzias has no financial relationships with companies related to this material.
_-The-Breakthrough-Antipsychotic-That-Could-Change-Everything.webp?t=1729528747 "KarXT (Cobenfy)_ The Breakthrough Antipsychotic That Could Change Everything.jpg")
RSS
